【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Pulmonary Fibrosis Overview 10
Therapeutics Development 11
Pipeline Products for Pulmonary Fibrosis – Overview 11
Pipeline Products for Pulmonary Fibrosis – Comparative Analysis 12
Pulmonary Fibrosis – Therapeutics under Development by Companies 13
Pulmonary Fibrosis – Therapeutics under Investigation by Universities/Institutes 19
Pulmonary Fibrosis – Pipeline Products Glance 20
Late Stage Products 20
Clinical Stage Products 21
Early Stage Products 22
Unknown Stage Products 23
Pulmonary Fibrosis – Products under Development by Companies 24
Pulmonary Fibrosis – Products under Investigation by Universities/Institutes 30
Pulmonary Fibrosis – Companies Involved in Therapeutics Development 31
AdAlta Pty Ltd. 31
Aeolus Pharmaceuticals, Inc. 32
AnaptysBio, Inc. 33
Angion Biomedica Corp. 34
Aquinox Pharmaceuticals Inc. 35
Auspex Pharmaceuticals, Inc. 36
Biogen Idec Inc. 37
BiOrion Technologies B.V. 38
Boehringer Ingelheim GmbH 39
Bristol-Myers Squibb Company 40
Carolus Therapeutics, Inc. 41
Celgene Corporation 42
Chong Kun Dang Pharmaceutical Corp. 43
Compugen Ltd. 44
Corridor Pharmaceuticals Inc. 45
Digna Biotech, S.L. 46
Eli Lilly and Company 47
F. Hoffmann-La Roche Ltd. 48
FibroGen, Inc. 49
Five Prime Therapeutics, Inc. 50
Galectin Therapeutics, Inc. 51
GenKyoTex S.A. 52
Gilead Sciences, Inc. 53
GlaxoSmithKline plc 54
HanAll Biopharma Co., Ltd. 55
Histocell S.L. 56
iBio, Inc. 57
IMMD Inc. 58
ImmuneWorks, LLC 59
IntelGenx Corp. 60
InterMune, Inc. 61
Inventiva SAS 62
Kasiak Research Pvt. Ltd. 63
Kyorin Pharmaceutical Co., Ltd. 64
Lanthio Pharma B.V. 65
Lpath, Inc. 66
LTT Bio-Pharma Co., Ltd. 67
MedImmune, LLC 68
Mesoblast Limited 69
miRagen Therapeutics, Inc. 70
Moerae Matrix, Inc. 71
MSM Protein Technologies, Inc. 72
NicOx S.A. 73
Pacific Therapeutics Ltd. 74
Pharmaxis Limited 75
Pluristem Therapeutics Inc. 76
Progenra, Inc. 77
Promedior, Inc. 78
ProMetic Life Sciences Inc. 79
Pulmatrix, Inc. 80
RestorGenex Corporation 81
Rhizen Pharmaceuticals SA 82
Sanofi 83
Therametrics holding AG 84
Vectura Group plc 85
Pulmonary Fibrosis – Therapeutics Assessment 86
Assessment by Monotherapy Products 86
Assessment by Combination Products 87
Assessment by Target 88
Assessment by Mechanism of Action 92
Assessment by Route of Administration 95
Assessment by Molecule Type 97
Drug Profiles 99
(pentoxifylline + acetylcysteine) – Drug Profile 99
ABC-294640 – Drug Profile 100
AEOL-10150 – Drug Profile 102
AM-0010 – Drug Profile 105
ANG-3070 – Drug Profile 106
ANG-3298 – Drug Profile 107
Antibodies to Inhibit LPA1 for Idiopathic Pulmonary Fibrosis – Drug Profile 108
AQX-1125 – Drug Profile 109
BB-3 – Drug Profile 111
BMS-986020 – Drug Profile 113
BOT-191 – Drug Profile 114
C-301 – Drug Profile 115
CC-539 – Drug Profile 116
CC-90001 – Drug Profile 117
CG-1011 – Drug Profile 118
CGEN-25009 – Drug Profile 119
CKD-942 – Drug Profile 120
CT-140 – Drug Profile 121
CT-2009 – Drug Profile 122
DB-02901 – Drug Profile 123
disitertide – Drug Profile 124
Drug for Idiopathic Pulmonary Fibrosis – Drug Profile 126
Drugs to Antagonize IGF-1 Receptor for Acute Lung Injury and Pulmonary Fibrosis – Drug Profile 127
FG-3019 – Drug Profile 128
FPA-008 – Drug Profile 130
GKT-137831 – Drug Profile 131
GR-MD-02 – Drug Profile 132
HC-016 – Drug Profile 134
HL-156FIB – Drug Profile 135
HR-017 – Drug Profile 136
IBIOCFB-03 – Drug Profile 137
ICG-001 – Drug Profile 138
IMD-1041 – Drug Profile 139
INT-0024 – Drug Profile 140
interferon gamma-1b – Drug Profile 141
ITMN-10534 – Drug Profile 142
ITMN-14440 – Drug Profile 143
ITMN-30162 – Drug Profile 144
IVA-337 – Drug Profile 145
IW-001 – Drug Profile 146
KBP-7018 – Drug Profile 147
lebrikizumab – Drug Profile 148
LP2 – Drug Profile 150
Lpathomab – Drug Profile 151
LT-0011 – Drug Profile 152
LY-2109761 – Drug Profile 153
MGN-4220 – Drug Profile 154
MMI-0100 – Drug Profile 155
Monoclonal Antibody for Idiopathic Pulmonary Fibrosis – Drug Profile 156
MSM-735 – Drug Profile 157
MSX-122 – Drug Profile 158
NAS-911 – Drug Profile 160
NCX-466 – Drug Profile 161
nintedanib – Drug Profile 162
Oligonucleotides for Respiratory and Oncology – Drug Profile 166
omipalisib – Drug Profile 167
P-007 – Drug Profile 168
P-17 – Drug Profile 169
P-529 – Drug Profile 171
PBF-1250 – Drug Profile 173
PBI-4050 – Drug Profile 174
phytate sodium – Drug Profile 175
pirfenidone – Drug Profile 176
PRI-724 – Drug Profile 177
PRM-151 – Drug Profile 179
PUR-1500 – Drug Profile 181
PXS-25 – Drug Profile 182
PXS-4820 – Drug Profile 183
PXS-5033-A – Drug Profile 184
PXS-64 – Drug Profile 185
Recombinant Human Follistatin – Drug Profile 186
Refacell-IPF – Drug Profile 187
RNAi Oligonucleotides for Idiopathic Pulmonary Fibrosis – Drug Profile 188
RP-6503 – Drug Profile 189
SAR-156597 – Drug Profile 190
SD-560 – Drug Profile 191
simtuzumab – Drug Profile 192
Small Molecule 1 for Chronic Respiratory Diseases – Drug Profile 194
Small Molecule 2 for Chronic Respiratory Diseases – Drug Profile 195
Small Molecule to Antagonize Integrin Alpha V for Idiopathic Pulmonary Fibrosis – Drug Profile 196
Small Molecule to Inhibit NOX 1 and 4 – Drug Profile 197
Small Molecules to Antagonize LPA1 Receptor for Pulmonary Fibrosis – Drug Profile 198
Small Molecules to Inhibit LOXL2 for Oncology and Fibrosis – Drug Profile 199
Small Molecules to Inhibit USP34 for Idiopathic Pulmonary Fibrosis – Drug Profile 200
SPL-334 – Drug Profile 201
Stem Cell Therapy for Asthma and Pulmonary Fibrosis – Drug Profile 202
Stem Cell Therapy for Idiopathic Lung Fibrosis – Drug Profile 203
Stem Cell Therapy for Pulmonary Fibrosis – Drug Profile 204
STX-100 – Drug Profile 205
Synthetic Peptides to Antagonize TGF-Beta Receptor for Diabetic Foot Ulcers, Pulmonary Fibrosis and Dermatology – Drug Profile 206
Synthetic Peptides to Inhibit PDE-4A4 for Pulmonary Fibrosis and Nerve Injury – Drug Profile 208
TD-139 – Drug Profile 209
tipelukast – Drug Profile 210
tralokinumab – Drug Profile 212
vismodegib – Drug Profile 214
Pulmonary Fibrosis – Recent Pipeline Updates 217
Pulmonary Fibrosis – Dormant Projects 265
Pulmonary Fibrosis – Discontinued Products 269
Pulmonary Fibrosis – Product Development Milestones 270
Featured News & Press Releases 270
Appendix 280
Methodology 280
Coverage 280
Secondary Research 280
Primary Research 280
Expert Panel Validation 280
Contact Us 281
Disclaimer 281
【レポート販売概要】
■ タイトル：肺線維症(Pulmonary Fibrosis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Pulmonary Fibrosis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6017IDB
■ 調査対象地域：グローバル
- 鉄鋼加工の世界市場：炭素鋼、合金鋼The global steel processing market is estimated to exhibit a lucrative growth potential of about 2.16% for the next five years. The growth of this market is propelled by an increase in the construction and automotive industry throughout the world. Also, the fact that there are no immediate substitutes of steel has made steel products an important part of daily lives of the people. With emergence o …
- 世界におけるバイオシミラー及び後続生物製剤市場（2014-2024）Biosimilar drugs – discover trends and segments with highest potential revenues Do you want to find sales potentials of biosimilars? Visiongain’s updated report gives you revenue predictions for those biological drugs from 2014, helping you stay ahead. For those therapies you find financial data, R&D trends, opportunities and selling prospects. In that new analysis you get sales forecasts to 2024 …
- CNC（コンピュータ数値制御）ソリューションの世界市場About CNC solutions CNC solutions are effective and efficient motion control systems that provide speedy and accurate execution of machining processes. These systems are deployed in manufacturing industries to create high-quality products. They are equipped with high-speed microprocessors to deliver high-precision machining processes with integrated safety functions for a foolproof and safe workin …
- バイオマテリアル（生体材料）の世界市場：金属系バイオマテリアル、セラミック系バイオマテリアル、ポリマー系バイオマテリアル、天然バイオマテリアルThe global biomaterials market is segmented on the basis of type of material and application. By type of material, the market is categorized into metallic, ceramic, polymers, and natural biomaterials. In 2015, the metallic segment is estimated to account for the larger share of the market. However, the polymers segment is expected to grow at the fastest rate during the forecast period. The metalli …
- 複合材料の世界市場：炭素繊維複合材、ガラス繊維複合材、アラミド繊維複合材、天然繊維複合材The composites market size of end products in terms of value is projected to reach around $90 billion by 2020 and expected to grow at a CAGR of 7% to 9% between 2015 and 2020. Asia-Pacific held the largest share by volume in composites market in 2014. Major growth in the Asia-Pacific region is expected from the growing construction, aerospace and electronics & semiconductor application. The compos …
- 通信事業者向けビックデータ分析ソリューションの世界市場About Big Data Analytics Big data is a huge volume of data that can be structured and unstructured and cannot be directly stored into a database without processing. Big data analytics refers to IT offerings that use various data mining techniques such as predictive modeling and text mining and helps telecom service providers to derive real-time actionable insights and aid in business decision maki …
- スマートプロセスアプリケーション（SPA）の世界市場Smart process application can be defined as the new type of application software aimed at reducing human error rates to improve the efficiency of human centric business activities. Now-a-days the businesses are looking out for different process solution that helps to improve the productivity of unstructured and people intensive activities, to increase the effectiveness of processes and decision ma …
- ソリッドステート･リレーの世界市場予測Solid state relays are semiconductor devices that are used to switch electricity to a load when a small external voltage is applied across its control terminals. They are very similar to an opto coupled devices but with a variation that these device use MOSFET transistors as the switching device. The solid state relays can be designed to switch either AC or DC to the load and have features such as …
- 日本の分子診断・NAT市場2014This report provides:Five-year sales forecasts for the Japanese Molecular Diagnostics market, including: - Infectious Diseases - & …
- 世界の非接続式スマートカード市場動向（2014-2018）About Contactless Smart Cards Smart cards are pocket-sized cards that are generally made of plastic and embedded with integrated circuits. They are mainly used for identification, authentication, data storage, and application processing. Smart cards are mainly of two types: contact-based and contactless. Contactless cards generally use radio-frequency induction technology for data and information …
- RFIDの世界市場2016-2020About the Radio Frequency Identification (RFID) Market An RFID system is based on wireless technology, which utilizes radio waves for gathering data from a tag attached to an object. It is used for different purposes such as for tracking objects and automatic identification. Components of RFID systems are mentioned below: • Tag (used for the distinct identification of an object) • Antenna (used to …
- コグニティブ・コンピューティングの世界市場分析：技術別（機械学習）、展開別（オンプレミス、クラウド）、用途別（BFSI、ヘルスケア、セキュリティ、小売、IT･電話通信、航空宇宙）、地域別、セグメント予測、2014-2025The global cognitive computing market size is expected to reach USD 49.36 billion by 2025, according to a new study conducted by Grand View Research, Inc. The surge in demand for the cognitive computing technology across North America and Europe is anticipated to drive the industry growth over the next nine years. It enables business organizations to incorporate advanced data analytics technology …
- 肺活量計の世界市場2016-2020About the Spirometer Market A spirometer is a medical apparatus used to measure the volume of air inspired and expired by the lungs. The device produces a spirogram that is a graphic record of the ventilation patterns of the lungs. Spirometers are used for basic pulmonary function tests (PFTs) to help detect respiratory diseases such as asthma, bronchitis, and emphysema. Technavio’s analysts forec …
- 患者エンゲージメント技術の世界市場：料金体系、置き換え動向、選定基準、購買行動Patient engagement technology is increasingly being adopted by healthcare providers, payers, and patients across the globe, particularly in the U.S. This report provides qualitative assessment of the patient engagement technologies in terms of pricing, vendor replacement trends, and selection criteria of adopting patient engagement technologies from provider perspective. The market is expected to …
- 自動車用X-By-Wireシステムの世界市場2018-2022109 Pages, November 2018 About this market Prognostics is the newly evolved form of automotive remote diagnostics with an intuitive software interface, which makes the work of the service technician easier and simpler. Though a similar technology with a different term 'preventive maintenance' had existed for more than a decade, General Motors was the first to launch prognostic technology through i …
